Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994
Although not all of these side effects may occur, if they do occur they may need medical attention
About Medicine
Prescribing information Mirtazapine Depression: Mirtazapine Last revised in November 2023 On this page Contraindications and cautions Adverse effects Drug interactions
It is also known by
If you have diabetes, mirtazapine can make it more difficult to keep your blood sugar stable
Medicines Mirtazapine for depression Zispin SolTab Last updated by Michael Stewart Peer reviewed by Sid Dajani Last updated 15 Mar 2023 Meets Patient’s
Introduction
Who can and cannot take it
Maintenance dose: 15 to 45 mg orally once a day
Serious side effects of Mirtazapine
red skin lesions, often with a purple center
If any of these effects last or get worse Mirtazapine (Oral Route) Mirtazapine is used to treat depression
These are just a few of the more common side effects reported by Mirtazapine is a commonly used antidepressant with a well-known ability to produce sedation
It is also a potent antagonist of 5-HT 2 and 5-HT 3 serotonin receptors and H 1 histamine receptors and a moderate peripheral alpha 1 Depressive Disorders
Mirtazapine is used to treat depression
VA class: CN609 Chemical name: 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido [2,3-c][2]benzazepine Molecular formula: C 17 H 19 N 3 CAS number: 61337-67-5
Suicidal thoughts, suicide (rare) Agranulocytosis
risk of serotonin syndrome, CNS depression, psychomotor impairment, hypotension (incl
This medication is used to treat depression
Synopsis: Mirtazapine is a tetracyclic antidepressant with a novel mechanism of action; it increases noradrenergic and serotonergic neurotransmission via blockade of central α2-adrenergic auto- and heteroreceptors
It reduces the duration of early, light stages of sleep and increases deep sleep 2 and also slightly reduces Mirtazapine orally disintegrating tablets and other antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, or young adults within thefirst few months of treatment or when the dose is changed
, and received FDA approval in 1997 for the treatment of major depressive disorder
Orodispersible (‘melt in your mouth’) tablets: 15mg, 30mg and 45mg strengths